Cytosorbents (CTSO) Operating Income (2011 - 2026)
Cytosorbents posted quarterly Operating Income of -$3.0 million for Q1 2026, up 21.71% year-on-year from -$2.5 million in Q1 2025, and up 30.58% on a QoQ basis from -$4.4 million in Q4 2025.
Cytosorbents (CTSO) has 16 years of Operating Income data on file, last reported at -$3.0 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income rose 21.71% year-over-year to -$3.0 million; the trailing twelve-month figure through Mar 2026 stood at -$13.9 million (up 11.33% YoY), and the FY2025 full-year result was -$14.7 million, up 10.35% from the prior year.
- Operating Income for Q1 2026 stood at -$3.0 million, up from -$4.4 million in the prior quarter.
- Across five years, Operating Income topped out at -$2.9 million in Q3 2025 and bottomed at -$9.4 million in Q4 2023.
- The 5-year median for Operating Income is -$4.8 million (2024), against an average of -$5.7 million.
- The widest annual swing landed in 2022, when Operating Income tumbled 173.16%; it then jumped 63.91% in 2024.
- A 5-year view of Operating Income shows it stood at -$6.4 million in 2022, then slumped by 48.01% to -$9.4 million in 2023, then surged by 63.91% to -$3.4 million in 2024, then retreated by 29.16% to -$4.4 million in 2025, then surged by 30.58% to -$3.0 million in 2026.
- The last three Operating Income figures came in at -$3.0 million (Q1 2026), -$4.4 million (Q4 2025), and -$2.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 282.15 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn | -3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.04 Mn |
| Dec 31, 2025 | -4.39 Mn |
| Sep 30, 2025 | -2.86 Mn |
| Jun 30, 2025 | -3.62 Mn |
| Mar 31, 2025 | -3.89 Mn |
| Dec 31, 2024 | -3.40 Mn |
| Sep 30, 2024 | -4.83 Mn |
| Jun 30, 2024 | -3.57 Mn |
| Mar 31, 2024 | -4.66 Mn |
| Dec 31, 2023 | -9.41 Mn |
| Sep 30, 2023 | -7.35 Mn |
| Jun 30, 2023 | -6.56 Mn |
| Mar 31, 2023 | -7.89 Mn |
| Dec 31, 2022 | -6.36 Mn |
| Sep 30, 2022 | -9.02 Mn |
| Jun 30, 2022 | -8.36 Mn |
| Mar 31, 2022 | -7.79 Mn |
| Dec 31, 2021 | -9.56 Mn |
| Sep 30, 2021 | -5.41 Mn |
| Jun 30, 2021 | -4.92 Mn |
| Mar 31, 2021 | -2.85 Mn |
| Dec 31, 2020 | -2.63 Mn |
| Sep 30, 2020 | -1.96 Mn |
| Jun 30, 2020 | -3.30 Mn |
| Mar 31, 2020 | -2.48 Mn |
| Dec 31, 2019 | -5.43 Mn |
| Sep 30, 2019 | -5.63 Mn |
| Jun 30, 2019 | -3.63 Mn |
| Mar 31, 2019 | -4.29 Mn |
| Dec 31, 2018 | -5.59 Mn |
| Sep 30, 2018 | -2.71 Mn |
| Jun 30, 2018 | -4.19 Mn |
| Mar 31, 2018 | -3.10 Mn |
| Dec 31, 2017 | -3.81 Mn |
| Sep 30, 2017 | -2.15 Mn |
| Jun 30, 2017 | -2.33 Mn |
| Mar 31, 2017 | -1.56 Mn |
| Dec 31, 2016 | -4.57 Mn |
| Sep 30, 2016 | -2.14 Mn |
| Jun 30, 2016 | -2.69 Mn |
| Mar 31, 2016 | -2.09 Mn |
| Dec 31, 2015 | -2.21 Mn |
| Sep 30, 2015 | -2.15 Mn |
| Jun 30, 2015 | -2.23 Mn |
| Mar 31, 2015 | -2.71 Mn |
| Dec 31, 2014 | -2.89 Mn |
| Sep 30, 2014 | -1.48 Mn |
| Jun 30, 2014 | -1.36 Mn |
| Mar 31, 2014 | -1.15 Mn |
| Dec 31, 2013 | -1.00 Mn |
| Sep 30, 2013 | -879,843.00 |
| Jun 30, 2013 | -1.41 Mn |
| Mar 31, 2013 | -1.42 Mn |
| Dec 31, 2012 | -812,926.00 |
| Sep 30, 2012 | -601,179.00 |
| Jun 30, 2012 | -1.01 Mn |
| Mar 31, 2012 | -1.07 Mn |
| Dec 31, 2011 | -968,432.00 |
| Sep 30, 2011 | -1.23 Mn |
| Jun 30, 2011 | -1.11 Mn |
| Mar 31, 2011 | -1.13 Mn |